Successfully treated spondylodiscitis due to a previously unreported mycobacterium.
A non-tuberculous mycobacterium was isolated, following a vertebral needle aspiration, from the blood of a patient with severe spondylodiscitis. The strain turned out to be different from any known mycobacterial species and was quite drug-susceptible in vitro. The patient improved markedly following treatment with meropenem, clarithromycin and amikacin.
Tortoli
Enrico
E
Mantella
Antonia
A
Infectious Diseases Unit, University of Florence, Florence, Italy.
Mariottini
Alessandro
A
Mazzarelli
Gianna
G
Pecile
Patrizia
P
Rogasi
Pier G
PG
Sterrantino
Gaetana
G
Fantoni
Elisa
E
Leoncini
Francesco
F
D000995:Antitubercular Agents / Q000627:therapeutic use*; D001483:Base Sequence; D021903:DNA, Ribosomal Spacer / Q000032:analysis; D015299:Discitis / Q000188:drug therapy* / Q000382:microbiology*; D020459:Genes, rRNA; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009161:Mycobacterium / Q000145:classification / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification*; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000382:microbiology; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D012338:RNA, Ribosomal, 23S / Q000235:genetics; D017422:Sequence Analysis, DNA; D016896:Treatment Outcome
D000995:Antitubercular Agents; D021903:DNA, Ribosomal Spacer; D012336:RNA, Ribosomal, 16S; D012338:RNA, Ribosomal, 23S